Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Medtronic: Enters definitive agreement to acquire Cupertino, California-based AneuRx, a development stage manufacturer of an endovascular stented graft and delivery system to repair abdominal aortic aneurysms. The AneuRx catheter-based system enables minimally invasive treatment of aneurysms through a small incision in a patient's groin. The system is "expected to enter U.S. clinical trials soon," according to Medtronic. Terms of the stock transaction with AneuRx were not disclosed. Medtronic recently has entered agreements to purchase two other companies in the interventional vascular field -- stent manufacturer InStent and interventional neuroradiology products firm Micro Interventional Systems...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel